Clinical Trial Update: Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for robatumumab (SCH 717454, MK-7454) in combination regimens in advanced solid tumors; study terminated with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• robatumumab (robatumumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Neoplasms | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-12-22